Drug Research
Centivax partners with US NMRC to study Covid-19 antibody
Centivax has signed a strategic collaboration with the US Naval Medical Research Center (NMRC) to conduct Phase I clinical development of its SARS-CoV-2 antibody,...
News
UK approves Johnson & Johnson’s single-dose Covid vaccine for use
The U.K.’s medicines regulator on Friday approved Janssen’s single-dose Covid-19 vaccine for use. Britain’s Medicines and Healthcare products Regulatory Agency said that doses were...
News
‘Black Mould’ [Mucormycosis] – the Dark Side of At-home and Self-COVID-19 Treatment
In fact, it’s not just this particular bug that we need to be concerned about. There are other cousins of mucor lurking in our...
News
‘COVIDASHA’, a technology shot to battle the 2nd wave of the pandemic
CovidAsha, a chatbot platform on the Web, WhatsApp and Telegram, is a unique initiative by conversational automation heavy-weights Engati, and healthcare ecosystem players like...
News
Onyx Scientific bolsters manufacturing capabilities with commercial API license
Onyx Scientific, a small molecule API contract development and manufacturing organisation has received a commercial API license for its UK facility.
The license, granted by...
News
Global exclusive as Iceni Diagnostics licences key virus detection IP from University of Warwick
Iceni Diagnostics, a specialist carbohydrate chemistry company based in Norwich, is delighted to announce that it has agreed an exclusive global licence, to integrate...
Industry Reports
Analysis of more than 160,000 COVID-19 patients shows obesity is the biggest indicator for severity of infection in under 40s
Virtual clinical development specialist, Phesi Inc., has today released findings from a significant analysis of COVID-19 patient profiles; based on data from 166,239 COVID-19...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read